These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1068 related articles for article (PubMed ID: 9262338)
1. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT(2A/2C) antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats. Kleven MS; Assié MB; Koek W J Pharmacol Exp Ther; 1997 Aug; 282(2):747-59. PubMed ID: 9262338 [TBL] [Abstract][Full Text] [Related]
2. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT2A/2C antagonist anxiolytics. I. Antipunishment effects in the pigeon. Kleven MS; Koek W J Pharmacol Exp Ther; 1996 Feb; 276(2):388-97. PubMed ID: 8632301 [TBL] [Abstract][Full Text] [Related]
3. (1-(2,5-dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists. Schreiber R; Brocco M; Audinot V; Gobert A; Veiga S; Millan MJ J Pharmacol Exp Ther; 1995 Apr; 273(1):101-12. PubMed ID: 7714755 [TBL] [Abstract][Full Text] [Related]
4. Differential effects of 5-HT agonists and antagonists on the repeated acquisition and performance of response sequences in monkeys. Winsauer PJ; Moerschbaecher JM Behav Pharmacol; 2000 Nov; 11(7-8):535-53. PubMed ID: 11198126 [TBL] [Abstract][Full Text] [Related]
5. Behavioral studies on LEK-8804, a new ergoline derivative with potent 5-HT1A receptor agonist and 5-HT2 receptor antagonist activity. Krisch I; Bole-Vunduk B Pharmacol Biochem Behav; 1994 Feb; 47(2):301-5. PubMed ID: 8146221 [TBL] [Abstract][Full Text] [Related]
6. S 14671: a naphtylpiperazine 5-hydroxytryptamine1A agonist of exceptional potency and high efficacy possessing antagonist activity at 5-hydroxytryptamine1C/2 receptors. Millan MJ; Rivet JM; Canton H; Lejeune F; Bervoets K; Brocco M; Gobert A; Lefebvre de Ladonchamps B; Le Marouille-Girardon S; Verriele L J Pharmacol Exp Ther; 1992 Aug; 262(2):451-63. PubMed ID: 1323650 [TBL] [Abstract][Full Text] [Related]
7. The stimulus effects of 8-OH-DPAT: evidence for a 5-HT2A receptor-mediated component. Reissig CJ; Eckler JR; Rabin RA; Rice KC; Winter JC Pharmacol Biochem Behav; 2008 Jan; 88(3):312-7. PubMed ID: 17936346 [TBL] [Abstract][Full Text] [Related]
8. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity. Millan MJ; Bervoets K; Colpaert FC J Pharmacol Exp Ther; 1991 Mar; 256(3):973-82. PubMed ID: 1826033 [TBL] [Abstract][Full Text] [Related]
9. Attenuation of nicotine's discriminative stimulus effects in rats and its locomotor activity effects in mice by serotonergic 5-HT2A/2C receptor agonists. Batman AM; Munzar P; Beardsley PM Psychopharmacology (Berl); 2005 May; 179(2):393-401. PubMed ID: 15565434 [TBL] [Abstract][Full Text] [Related]
10. Genomic responses to 5-HT1A or 5-HT2A/2C receptor activation is differentially regulated in four regions of rat brain. Tilakaratne N; Friedman E Eur J Pharmacol; 1996 Jun; 307(2):211-7. PubMed ID: 8832223 [TBL] [Abstract][Full Text] [Related]
11. N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline studies on the role of 5-HT1A and 5-HT2 receptors in mediating foot-shock-induced ultrasonic vocalisation in adult rats. Sánchez C; Mørk A Eur Neuropsychopharmacol; 1999 Jun; 9(4):287-94. PubMed ID: 10422888 [TBL] [Abstract][Full Text] [Related]
12. Two selective 5-HT1A receptor antagonists, WAY-100 635 and NDL-249, stimulate locomotion in rats acclimatised to their environment and alter their behaviour: a behavioural analysis. Jackson DM; Wallsten CE; Jerning E; Hu PS; Deveney AM Psychopharmacology (Berl); 1998 Oct; 139(4):300-10. PubMed ID: 9809851 [TBL] [Abstract][Full Text] [Related]
13. A drug discrimination analysis of the actions of novel serotonin1A receptor ligands in the rat using the 5-HT1A receptor agonist, 8-hydroxy-2-(di-n-propylamino)tetralin. Schreiber R; Brocco M; Lefèbvre de Ladonchamps B; Monneyron S; Millan MJ J Pharmacol Exp Ther; 1995 Nov; 275(2):822-31. PubMed ID: 7473172 [TBL] [Abstract][Full Text] [Related]
14. The putative 5-HT1A receptor antagonist DU125530 blocks the discriminative stimulus of the 5-HT1A receptor agonist flesinoxan in pigeons. Mos J; Van Hest A; Van Drimmelen M; Herremans AH; Olivier B Eur J Pharmacol; 1997 May; 325(2-3):145-53. PubMed ID: 9163561 [TBL] [Abstract][Full Text] [Related]
15. Analysis of the 5-HT1A receptor involvement in passive avoidance in the rat. Misane I; Johansson C; Ogren SO Br J Pharmacol; 1998 Oct; 125(3):499-509. PubMed ID: 9806333 [TBL] [Abstract][Full Text] [Related]
17. Discriminative stimulus effects of 8-OH-DPAT in pigeons: antagonism studies with the putative 5-HT1A receptor antagonists BMY 7378 and NAN-190. Barrett JE; Gleeson S Eur J Pharmacol; 1992 Jul; 217(2-3):163-71. PubMed ID: 1425937 [TBL] [Abstract][Full Text] [Related]
18. Discriminative stimulus properties of indorenate, a 5-HT1A, 5-HT1B and 5-HT2C agonist: a study in rats. Sánchez H; Velázquez-Martínez DN J Psychopharmacol; 2001 Mar; 15(1):29-36. PubMed ID: 11277605 [TBL] [Abstract][Full Text] [Related]
19. A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors. Goodwin GM; Green AR Br J Pharmacol; 1985 Mar; 84(3):743-53. PubMed ID: 2580582 [TBL] [Abstract][Full Text] [Related]
20. Effects of the serotonin 5-HT2A and 5-HT2C receptor ligands on the discriminative stimulus effects of nicotine in rats. Zaniewska M; McCreary AC; Przegaliński E; Filip M Eur J Pharmacol; 2007 Oct; 571(2-3):156-65. PubMed ID: 17617403 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]